Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
11.37
+0.36 (3.27%)
At close: Apr 28, 2026, 4:00 PM EDT
11.37
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:47 PM EDT
Keros Therapeutics Employees
Keros Therapeutics had 78 employees as of December 31, 2025. The number of employees decreased by 91 or -53.85% compared to the previous year.
Employees
78
Change (1Y)
-91
Growth (1Y)
-53.85%
Revenue / Employee
$3,128,987
Profits / Employee
$1,115,564
Market Cap
224.99M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Codexis | 146 |
| Voyager Therapeutics | 141 |
| Heron Therapeutics | 128 |
| MediWound | 121 |
| Camp4 Therapeutics | 48 |
| ALX Oncology Holdings | 43 |
| Milestone Pharmaceuticals | 38 |
| Fennec Pharmaceuticals | 35 |
KROS News
- 7 weeks ago - Keros Therapeutics Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Keros Therapeutics Presents Additional Clinical Data from Its Rinvatercept Program at the 2026 MDA Clinical & Scientific Conference - GlobeNewsWire
- 7 weeks ago - Keros Therapeutics Announces Collaboration with Sean M. Healey & AMG Center for ALS - GlobeNewsWire
- 7 weeks ago - Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 2 months ago - Keros Therapeutics Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Keros Therapeutics Appoints Charles Newton to its Board of Directors - GlobeNewsWire
- 2 months ago - Keros Therapeutics Transcript: Oppenheimer 36th Annual Healthcare Life Sciences Conference - Transcripts
- 2 months ago - Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences - GlobeNewsWire